Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy

Abstract The hepatitis B virus (HBV) infection continues to pose its own share of health challenges in the world with almost 296 million infected and over 820,000 liver related deaths happening every year. The existing drugs such as nucleoside analogues and interferon-alpha can suppress the replicat...

Descripció completa

Dades bibliogràfiques

Autors principals:	Samuel Chima Ugbaja, Reuben Samson Dangana, Idris Olatunji Sanusi, Olukayode Adebola Ibitoye, Asekho Nkungu, Lwandiswa Mafuleka, Moses Okpeku, Nceba Gqaleni
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2026-04-01
Col·lecció:	Discover Artificial Intelligence
Matèries:	Artificial intelligence Machine learning Drug repurposing Hepatitis B virus Virtual screening
Accés en línia:	https://doi.org/10.1007/s44163-026-01263-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!